Answers are grounded in this paper and cite their sources.
Lung cancer screening (LCS) among at-risk individuals reduces lung cancer-related mortality, and the United States Preventive Services Task Force has recommended screening in this population since 2013.1 Unfortunately, only between 5% and 18% of eligible individuals have undergone LCS.2 By contrast, breast cancer screening (BCS) has been adopted widely, with uptake nearing 70% nationally.3 More than 70% of women eligible for LCS underwent other cancer screening with some combination of breast and colorectal cancer screening, and 7% of women undergoing BCS are eligible for LCS, suggesting a missed opportunity.
No takes yet. Share an insight, caveat, or question.
Sweetnam et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: